Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01971515
Title First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors EMD Serono
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
University of California at San Diego, Moores Cancer Center San Diego California 92093 United States Details
Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Metairie Oncology Metairie Louisiana 70006 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Mount Sinai New York New York 10029 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75251 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 United States Details
Fletcher Allen Health Care, Inc. Burlington Vermont 05401 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field